A

Arbutus Biopharma Corp
D

ABUS

3.50500
USD
0.05
(1.30%)
Market Closed
Volume
26,519
EPS
-1
Div Yield
-
P/E
-8
Market Cap
664,168,356
OverviewSignalsIdeasNews
Related Instruments
    A
    ADVM
    -0.40000
    (-5.51%)
    6.86000 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    V
    VBIV
    0
    (0%)
    0.000000 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.72 USD
    More
News

Title: Arbutus Biopharma Corp

Sector: Healthcare
Industry: Biotechnology
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.